|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.56 CNY | +1.23% |
|
+6.67% | -4.93% |
Yabao Pharmaceutical Group Co., Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 1,532.84 million compared to CNY 1,293.92 million a year ago. Net income was CNY 168.03 million compared to CNY 100.4 million a year ago.
Basic earnings per share from continuing operations was CNY 0.2182 compared to CNY 0.1304 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.93% | 640M | |
| +19.27% | 43.18B | |
| +21.27% | 23.23B | |
| +15.11% | 14.6B | |
| +38.36% | 11.5B | |
| -8.43% | 6.79B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.31B | |
| -2.27% | 4.81B |
YABAO PHARMACEUTICAL GROUP CO., LTD 
